Key result
In rats with induced type 2 diabetes, six weeks of PAGR administration significantly decreased fasting blood glucose, total cholesterol, and triglycerides while improving antioxidant capacity.
Why the study?
Does Purified Anthraquinone-Glycoside Preparation from Rheum Palmatum L. (PAGR) improve metabolic parameters and reduce tissue damage in a rat model of type 2 diabetes mellitus?
Does Purified Anthraquinone-Glycoside Preparation from Rheum Palmatum L. (PAGR) improve metabolic parameters and reduce tissue damage in a rat model of type 2 diabetes mellitus?
PAGR improves blood glucose and lipid metabolism and reduces oxidative stress and apoptosis in a rat model of type 2 diabetes mellitus.
L. (PAGR) in streptozotocin (STZ) and high-fat diet induced type 2 diabetes mellitus (T2DM) in rats was investigated. The rats were randomly divided into normal (NC), T2DM, metformin (Met), low, middle (Mid), and high (Hig) does of PAGR groups. After six weeks of continuous administration of PAGR, the serum indices and tissue protein expression were determined, and the pathological changes in liver, kidney, and pancreas tissues were observed. The results showed that compared with the type 2 diabetes mellitus group, the fasting blood glucose (FBG), total cholesterol (TC), and triglyceride (TG) levels in the serum of rats in the PAGR treatment groups were significantly decreased, while superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX) levels were noticeably increased. The expression of Fas ligand (FasL), cytochrome C (Cyt-c), and caspase-3 in pancreatic tissue was obviously decreased, and the pathological damage to the liver, kidney, and pancreas was improved. These indicate that PAGR can reduce oxidative stress in rats with diabetes mellitus by improving blood lipid metabolism and enhancing their antioxidant capacity, thereby regulating the mitochondrial apoptotic pathway to inhibitβ-cell apoptosis and improve β-cell function. Furthermore, it can regulate Fas/FasL-mediated apoptosis signaling pathway to inhibit β-cell apoptosis, thereby lowering blood glucose levels and improving T2DM.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2019) studied Type 2 diabetes mellitus (T2DM). Purified Anthraquinone-Glycoside Preparation from Rheum Palmatum L. (PAGR) vs. Normal control, T2DM control, and metformin was evaluated on Fasting blood glucose, total cholesterol, triglyceride levels, and tissue protein expression. In rats with induced type 2 diabetes, six weeks of PAGR administration significantly decreased fasting blood glucose, total cholesterol, and triglycerides while improving antioxidant capacity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: